Prognostic role of proliferating CD8
Breast cancer
CD8+ cytotoxic Tcells
Colorectal cancer
Gastric cancer
Ovarian cancer
Pancreatic cancer
Renal cell cancer
Tumor microenvironment
Journal
Cellular oncology (Dordrecht)
ISSN: 2211-3436
Titre abrégé: Cell Oncol (Dordr)
Pays: Netherlands
ID NLM: 101552938
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
accepted:
02
03
2021
pubmed:
18
4
2021
medline:
11
1
2022
entrez:
17
4
2021
Statut:
ppublish
Résumé
Expansion of CD8 To understand the CD8 The density and the percentage of proliferating (Ki67 Our data demonstrate a tumor type dependent prognostic impact of proliferating (Ki67
Identifiants
pubmed: 33864611
doi: 10.1007/s13402-021-00601-4
pii: 10.1007/s13402-021-00601-4
pmc: PMC8338812
doi:
Substances chimiques
Ki-67 Antigen
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
793-803Informations de copyright
© 2021. The Author(s).
Références
N.C. Blessin, P. Spriestersbach, W. Li, T. Mandelkow, D. Dum, R. Simon, C. Hube-Magg, F. Lutz, F. Viehweger, M. Lennartz, C. Fraune, V. Nickelsen, W. Fehrle, C. Gobel, S. Weidemann, T. Clauditz, P. Lebok, K. Moller, S. Steurer, J.R. Izbicki, G. Sauter, S. Minner, F. Jacobsen, A.M. Luebke, F. Buscheck, D. Hoflmayer, W. Wilczak, E. Burandt, A. Hinsch, Prevalence of CD8(+) cytotoxic lymphocytes in human neoplasms. Cell. Oncol. 43, 421–430 (2020)
J. Galon, A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pages, M. Tosolini, M. Camus, A. Berger, P. Wind, F. Zinzindohoue, P. Bruneval, P.H. Cugnenc, Z. Trajanoski, W.H. Fridman, F. Pages, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006)
pubmed: 17008531
doi: 10.1126/science.1129139
J. Galon, F. Pages, F.M. Marincola, M. Thurin, G. Trinchieri, B.A. Fox, T.F. Gajewski, P.A. Ascierto, The immune score as a new possible approach for the classification of cancer. J. Transl. Med. 10, 1 (2012)
pubmed: 22214470
pmcid: 3269368
doi: 10.1186/1479-5876-10-1
P.C. Tumeh, C.L. Harview, J.H. Yearley, I.P. Shintaku, E.J. Taylor, L. Robert, B. Chmielowski, M. Spasic, G. Henry, V. Ciobanu, A.N. West, M. Carmona, C. Kivork, E. Seja, G. Cherry, A.J. Gutierrez, T.R. Grogan, C. Mateus, G. Tomasic, J.A. Glaspy, R.O. Emerson, H. Robins, R.H. Pierce, D.A. Elashoff, C. Robert, A. Ribas, PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568–571 (2014)
pubmed: 25428505
pmcid: 4246418
doi: 10.1038/nature13954
W. Yao, J.C. He, Y. Yang, J.M. Wang, Y.W. Qian, T. Yang, L. Ji, The prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A systematic review and meta-analysis. Sci. Rep. 7, 7525 (2017)
pubmed: 28790445
pmcid: 5548736
doi: 10.1038/s41598-017-08128-1
D.S. Chen, I. Mellman, Elements of cancer immunity and the cancer-immune set point. Nature 541, 321–330 (2017)
pubmed: 28102259
doi: 10.1038/nature21349
G.L. Beatty, W.L. Gladney, Immune escape mechanisms as a guide for cancer immunotherapy. Clin. Cancer Res. 21, 687–692 (2015)
pubmed: 25501578
doi: 10.1158/1078-0432.CCR-14-1860
P.S. Hegde, V. Karanikas, S. Evers, The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition. Clin. Cancer Res. 22, 1865–1874 (2016)
L. Galluzzi, A. Buque, O. Kepp, L. Zitvogel, G. Kroemer, Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell 28, 690–714 (2015)
pubmed: 26678337
doi: 10.1016/j.ccell.2015.10.012
R.S. Herbst, J.C. Soria, M. Kowanetz, G.D. Fine, O. Hamid, M.S. Gordon, J.A. Sosman, D.F. McDermott, J.D. Powderly, S.N. Gettinger, H.E. Kohrt, L. Horn, D.P. Lawrence, S. Rost, M. Leabman, Y. Xiao, A. Mokatrin, H. Koeppen, P.S. Hegde, I. Mellman, D.S. Chen, F.S. Hodi, Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 515, 563–567 (2014)
pubmed: 25428504
pmcid: 4836193
doi: 10.1038/nature14011
S. Halle, K.A. Keyser, F.R. Stahl, A. Busche, A. Marquardt, X. Zheng, M. Galla, V. Heissmeyer, K. Heller, J. Boelter, K. Wagner, Y. Bischoff, R. Martens, A. Braun, K. Werth, A. Uvarovskii, H. Kempf, M. Meyer-Hermann, R. Arens, M. Kremer, G. Sutter, M. Messerle, R. Forster, In vivo killing capacity of cytotoxic T cells is limited and involves dynamic interactions and T cell Cooperativity. Immunity 44, 233–245 (2016)
S.E. Stanton, M.L. Disis, Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J. Immunother. Cancer 4, 59 (2016)
pubmed: 27777769
pmcid: 5067916
doi: 10.1186/s40425-016-0165-6
M. Uso, E. Jantus-Lewintre, R.M. Bremnes, S. Calabuig, A. Blasco, E. Pastor, I. Borreda, S. Molina-Pinelo, L. Paz-Ares, R. Guijarro, M. Martorell, J. Forteza, C. Camps, R. Sirera, Analysis of the immune microenvironment in resected non-small cell lung cancer: The prognostic value of different T lymphocyte markers. Oncotarget 7, 52849–52861 (2016)
pubmed: 27463005
pmcid: 5288153
doi: 10.18632/oncotarget.10811
R.D. Gartrell, D.K. Marks, T.D. Hart, G. Li, D.R. Davari, A. Wu, Z. Blake, Y. Lu, K.N. Askin, A. Monod, C.L. Esancy, E.C. Stack, D.T. Jia, P.M. Armenta, Y. Fu, D. Izaki, B. Taback, R. Rabadan, H.L. Kaufman, C.G. Drake, B.A. Horst, Y.M. Saenger, Quantitative analysis of immune infiltrates in primary melanoma. Cancer Immunol. Res. 6, 481–493 (2018)
pubmed: 29467127
pmcid: 5882545
doi: 10.1158/2326-6066.CIR-17-0360
Y. Naito, K. Saito, K. Shiiba, A. Ohuchi, K. Saigenji, H. Nagura, H. Ohtani, CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 58, 3491–3494 (1998)
pubmed: 9721846
O. Nakano, M. Sato, Y. Naito, K. Suzuki, S. Orikasa, M. Aizawa, Y. Suzuki, I. Shintaku, H. Nagura, H. Ohtani, Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: Clinicopathologic demonstration of antitumor immunity. Cancer Res. 61, 5132–5136 (2001)
pubmed: 11431351
N.A. Giraldo, E. Becht, F. Pages, G. Skliris, V. Verkarre, Y. Vano, A. Mejean, N. Saint-Aubert, L. Lacroix, I. Natario, A. Lupo, M. Alifano, D. Damotte, A. Cazes, F. Triebel, G.J. Freeman, M.C. Dieu-Nosjean, S. Oudard, W.H. Fridman, C. Sautes-Fridman, Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer. Clin. Cancer Res. 21, 3031–3040 (2015)
T. Chiba, H. Ohtani, T. Mizoi, Y. Naito, E. Sato, H. Nagura, A. Ohuchi, K. Ohuchi, K. Shiiba, Y. Kurokawa, S. Satomi, Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: Possible association with suppression of micrometastasis. Br. J. Cancer 91, 1711–1717 (2004)
pubmed: 15494715
pmcid: 2410024
doi: 10.1038/sj.bjc.6602201
J. Gerdes, U. Schwab, H. Lemke, H. Stein, Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31, 13–20 (1983)
pubmed: 6339421
doi: 10.1002/ijc.2910310104
A. Soares, L. Govender, J. Hughes, W. Mavakla, M. de Kock, C. Barnard, B. Pienaar, E. Janse van Rensburg, G. Jacobs, G. Khomba, L. Stone, B. Abel, T.J. Scriba, W.A. Hanekom, Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J. Immunol. Methods 362, 43–50 (2010)
pubmed: 20800066
pmcid: 2989440
doi: 10.1016/j.jim.2010.08.007
N. Zhang, M.J. Bevan, CD8(+) T cells: Foot soldiers of the immune system. Immunity 35, 161–168 (2011)
pubmed: 21867926
pmcid: 3303224
doi: 10.1016/j.immuni.2011.07.010
K. Imaizumi, T. Suzuki, M. Kojima, M. Shimomura, N. Sakuyama, Y. Tsukada, T. Sasaki, Y. Nishizawa, A. Taketomi, M. Ito, T. Nakatsura, Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer. Cancer Sci. 111, 23–35 (2020)
pubmed: 31660687
doi: 10.1111/cas.14223
W. Shah, X. Yan, L. Jing, Y. Zhou, H. Chen, Y. Wang, A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cell. Mol. Immunol. 8, 59–66 (2011)
pubmed: 21200385
doi: 10.1038/cmi.2010.56
J. Kononen, L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton, J. Torhorst, M.J. Mihatsch, G. Sauter, O.P. Kallioniemi, Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4, 844–847 (1998)
pubmed: 9662379
doi: 10.1038/nm0798-844
S. Tippmann, Programming tools: Adventures with R. Nature 517, 109–110 (2015)
pubmed: 25557714
doi: 10.1038/517109a
R-Core-Team, R: A language and environment for statistical computing, R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/ . (2018). Accessed 01.12.2019
X. Hu, Y.Q. Li, Q.G. Li, Y.L. Ma, J.J. Peng, S.J. Cai, ITGAE defines CD8+ tumor-infiltrating lymphocytes predicting a better prognostic survival in colorectal Cancer. EBioMedicine 35, 178–188 (2018)
pubmed: 30100393
pmcid: 6154785
doi: 10.1016/j.ebiom.2018.08.003
G.E. Idos, J. Kwok, N. Bonthala, L. Kysh, S.B. Gruber, C. Qu, The prognostic implications of tumor infiltrating lymphocytes in colorectal cancer: A systematic review and meta-analysis. Sci. Rep. 10, 3360 (2020)
Y. Mao, Q. Qu, X. Chen, O. Huang, J. Wu, K. Shen, The prognostic value of tumor-infiltrating lymphocytes in breast cancer: A systematic review and meta-analysis. PLoS One 11, e0152500 (2016)
J.S. Lee, H.S. Won, S. Sun, J.H. Hong, Y.H. Ko, Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis. Medicine (Baltimore) 97, e11769 (2018)
doi: 10.1097/MD.0000000000011769
J. Li, J. Wang, R. Chen, Y. Bai, X. Lu, The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer. Oncotarget 8, 15621–15631 (2017)
pubmed: 28152503
pmcid: 5362510
doi: 10.18632/oncotarget.14919
F. Guo, Y. Dong, Q. Tan, J. Kong, B. Yu, Tissue infiltrating immune cells as prognostic biomarkers in endometrial cancer: A meta-analysis. Dis. Markers 2020, 1805764 (2020)
X. Zheng, X. Song, Y. Shao, B. Xu, W. Hu, Q. Zhou, L. Chen, D. Zhang, C. Wu, J. Jiang, Prognostic role of tumor-infiltrating lymphocytes in esophagus cancer: A meta-analysis. Cell. Physiol. Biochem. 45, 720–732 (2018)
Y. Masugi, T. Abe, A. Ueno, Y. Fujii-Nishimura, H. Ojima, Y. Endo, Y. Fujita, M. Kitago, M. Shinoda, Y. Kitagawa, M. Sakamoto, Characterization of spatial distribution of tumor-infiltrating CD8(+) T cells refines their prognostic utility for pancreatic cancer survival. Mod. Pathol. 32, 1495–1507 (2019)
pubmed: 31186528
doi: 10.1038/s41379-019-0291-z
T.A. Barnes, E. Amir, HYPE or HOPE: The prognostic value of infiltrating immune cells in cancer. Br. J. Cancer 117, 451–460 (2017)
pubmed: 28704840
pmcid: 5558691
doi: 10.1038/bjc.2017.220
Reiswich, N. Blessin, A. Rolschewski, F. Lutz, T. Mandelkow, W. Li, W. Yang, R. Simon, F. Büscheck, R. Uhlig, L. Wölber, S. Mahner, N. De Gregorio, R. Klapdor, M. Kalder, S. Steurer, W. Wilczak, C. Fraune and E. Burandt, T cell density at the invasive margin and immune phenotypes predict patient’s outcome in vulvar carcinomas, Unpublished (2021)
N.C. Blessin, R. Abu-Hashem, T. Mandelkow, W. Li, R. Simon, C. Hube-Magg, C. Möller-Koop, M. Witt, F. Büscheck, C. Fraune, A.M. Luebke, K. Möller, J. Jacobsen, F. Lutz, M. Lennartz, S. Steurer, G. Sauter, D. Höflmayer, M.C. Tsourlakis, A. Hinsch, E. Burandt, W. Wilczak, S. Minner and T. Clauditz, Prevalence of proliferating CD8+ cells in normal lymphatic tissues, inflammation and cancer, Unpublished (2021)
R.L. Giuntoli 2nd, J. Lu, H. Kobayashi, R. Kennedy, E. Celis, Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function. Clin. Cancer Res. 8, 922–931 (2002)
pubmed: 11895927
M. Motamedi, L. Xu, S. Elahi, Correlation of transferrin receptor (CD71) with Ki67 expression on stimulated human and mouse T cells: The kinetics of expression of T cell activation markers. J. Immunol. Methods 437, 43–52 (2016)
pubmed: 27555239
doi: 10.1016/j.jim.2016.08.002
A.O. Kamphorst, R.N. Pillai, S. Yang, T.H. Nasti, R.S. Akondy, A. Wieland, G.L. Sica, K. Yu, L. Koenig, N.T. Patel, M. Behera, H. Wu, M. McCausland, Z. Chen, C. Zhang, F.R. Khuri, T.K. Owonikoko, R. Ahmed, S.S. Ramalingam, Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients. Proc. Natl. Acad. Sci. U. S. A. 114, 4993–4998 (2017)
pubmed: 28446615
pmcid: 5441721
doi: 10.1073/pnas.1705327114
A. Maity, R. Mick, A.C. Huang, S.M. George, M.D. Farwell, J.N. Lukens, A.T. Berman, T.C. Mitchell, J. Bauml, L.M. Schuchter, M. O'Hara, L.L. Lin, A. Demichele, J.P. Christodouleas, N.B. Haas, D.M. Patsch, S.M. Hahn, A.J. Minn, E.J. Wherry, R.H. Vonderheide, A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours. Br. J. Cancer 119, 1200–1207 (2018)
pubmed: 30318516
pmcid: 6251028
doi: 10.1038/s41416-018-0281-9
M. Ahmadzadeh, L.A. Johnson, B. Heemskerk, J.R. Wunderlich, M.E. Dudley, D.E. White, S.A. Rosenberg, Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114, 1537–1544 (2009)
pubmed: 19423728
pmcid: 2927090
doi: 10.1182/blood-2008-12-195792
A.P. Ganesan, J. Clarke, O. Wood, E.M. Garrido-Martin, S.J. Chee, T. Mellows, D. Samaniego-Castruita, D. Singh, G. Seumois, A. Alzetani, E. Woo, P.S. Friedmann, E.V. King, G.J. Thomas, T. Sanchez-Elsner, P. Vijayanand, C.H. Ottensmeier, Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. Nat. Immunol. 18, 940–950 (2017)
pubmed: 28628092
pmcid: 6036910
doi: 10.1038/ni.3775
X. Liu, R.M. Gibbons, S.M. Harrington, C.J. Krco, S.N. Markovic, E.D. Kwon, H. Dong, Endogenous tumor-reactive CD8(+) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth. Oncoimmunology 2, e23972 (2013)
pubmed: 23894697
pmcid: 3716732
doi: 10.4161/onci.23972
E.D. Thompson, H.L. Enriquez, Y.X. Fu, V.H. Engelhard, Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. J. Exp. Med. 207, 1791–1804 (2010)
pubmed: 20660615
pmcid: 2916130
doi: 10.1084/jem.20092454
S.J. Golby, C. Chinyama, J. Spencer, Proliferation of T-cell subsets that contact tumour cells in colorectal cancer. Clin. Exp. Immunol. 127, 85–91 (2002)
pubmed: 11882037
pmcid: 1906282
doi: 10.1046/j.1365-2249.2002.01730.x
V. Golubovskaya and L. Wu, Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy, Cancers (Basel) 8, 36 (2016)
B. Mlecnik, G. Bindea, H.K. Angell, M.S. Sasso, A.C. Obenauf, T. Fredriksen, L. Lafontaine, A.M. Bilocq, A. Kirilovsky, M. Tosolini, M. Waldner, A. Berger, W.H. Fridman, A. Rafii, V. Valge-Archer, F. Pages, M.R. Speicher, J. Galon, Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients. Sci. Transl. Med. 6, 228ra237 (2014)
doi: 10.1126/scitranslmed.3007240
M.L. Eich, A. Chaux, M.A. Mendoza Rodriguez, G. Guner, D. Taheri, M.D.C. Rodriguez Pena, R. Sharma, M.E. Allaf, G.J. Netto, Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma. Histopathology 76, 423–432 (2020)
pubmed: 31494951
doi: 10.1111/his.13987
J.M. Kim, D.S. Chen, Immune escape to PD-L1/PD-1 blockade: Seven steps to success (or failure). Ann. Oncol. 27, 1492–1504 (2016)
pubmed: 27207108
doi: 10.1093/annonc/mdw217
S. Edin, T. Kaprio, J. Hagstrom, P. Larsson, H. Mustonen, C. Bockelman, K. Strigard, U. Gunnarsson, C. Haglund, R. Palmqvist, The prognostic importance of CD20(+) B lymphocytes in colorectal Cancer and the relation to other immune cell subsets. Sci. Rep. 9, 19997 (2019)
pubmed: 31882709
pmcid: 6934737
doi: 10.1038/s41598-019-56441-8
R. Matkowski, I. Gisterek, A. Halon, A. Lacko, K. Szewczyk, U. Staszek, M. Pudelko, B. Szynglarewicz, J. Szelachowska, A. Zolnierek, J. Kornafel, The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Anticancer Res. 29, 2445–2451 (2009)
pubmed: 19596912
B. Shang, Y. Liu, S.J. Jiang, Y. Liu, Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: A systematic review and meta-analysis. Sci. Rep. 5, 15179 (2015)
pubmed: 26462617
pmcid: 4604472
doi: 10.1038/srep15179